-+ 0.00%
-+ 0.00%
-+ 0.00%

CMS confirms pass-through payments for Lantheus’ PYLARIFY TruVu through September 2029

PUBT·11/05/2026 12:27:16
Listen to the news
CMS confirms pass-through payments for Lantheus’ PYLARIFY TruVu through September 2029
  • CMS's 2027 hospital outpatient payment final rule maintains separate reimbursement for qualifying diagnostic radiopharmaceuticals, supporting access to Lantheus products.
  • PYLARIFY TruVu will receive Transitional Pass-Through payments through September 30, 2029, covering the full three-year period.
  • Permanent billing code A9613, effective October 1, 2026, facilitates provider reimbursement for PYLARIFY TruVu.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantheus Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611050715PRIMZONEFULLFEED9871137) on November 05, 2026, and is solely responsible for the information contained therein.